Concentration of Credit Risk and Current Expected Credit Losses - Narrative (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Concentration of risk
Allowance for doubtful accounts	$ 0	$ 0
Novartis and Lilly | Accounts Receivable | Credit Concentration Risk
Concentration of risk
Percentage of concentration risk	21.00%	20.00%
Customer A, B, C, D, E and F | Accounts Receivable | Credit Concentration Risk
Concentration of risk
Percentage of concentration risk	53.00%	48.00%